Krystyna Dobrowolska

12PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infectious diseasesAdolescent healthMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Risk of Liver and Non-Liver Malignancy in HCV-Infected Patients with Cirrhosis After Direct-Acting Antiviral Treatment.

|Feb 13, 2026
Predictors of Severe Outcomes in COVID-19: Evidence from Real-World Multicenter Retrospective Study (2020-2024).

Małgorzata Wajdowicz, Krystyna Dobrowolska, Kinga Brzdęk

|Nov 20, 2025
Pangenotypic Glecaprevir/Pibrentasvir Therapy for Chronic Hepatitis C in Children.

Małgorzata Pawłowska, Dorota Zarębska-Michaluk, Krystyna Dobrowolska

|Sep 13, 2025
Differences in the Clinical Course of COVID-19 in Patients Hospitalized in the 2023/2024 and 2024/2025 Seasons.

Robert Flisiak, Dorota Zarębska-Michaluk, Michał Brzdęk

|Jul 18, 2025
Trends and Socio-Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12-Year Nationwide Analysis.

Agnieszka Genowska, Krystyna Dobrowolska, Dorota Zarębska-Michaluk

|Jan 08, 2025
Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.

Robert Flisiak, Dorota Zarębska-Michaluk, Diana Martonik

Pageof 2

Frequent Collaborators

11 joint publications

Dorota Zarebska-Michaluk

8 joint publications

Piotr Rzymski

7 joint publications

Robert Flisiak

4 joint publications

Michał Brzdęk